Here are the 10-K annual reports from Piermont Valley Acq (CMCAF) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow CMCAF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CMCAF filings page.
Piermont Valley Acquisition Corp, a Cayman Islands SPAC, filed its annual report describing its status, risks and plans to complete a merger before March 3, 2027. The company has repeatedly extended its deadline and, after several large redemption rounds, now has 5,954,449 Class A shares and 1 Class B share outstanding.
The report highlights a pending business combination with Tigerless Health via a multi-step merger into a new Nevada holding company, where former Tigerless stockholders are expected to own a majority. As of March 31, 2026, the trust account is anticipated to be about $12.02 per public share, and if no deal is completed by the deadline the SPAC will liquidate and redeem public shares.
Terms include up to $100 million of stock-based earn-out for Tigerless holders tied to multi-year performance milestones and a targeted PIPE raise of at least $5 million, which is not yet committed. The filing also notes prior termination of a Lexasure transaction and the company’s 2024 delisting from Nasdaq after missing the 36‑month business combination window.